InvestSMART

Prescient Therapeutics Limited (ASX: PTX) - Announcements

- Current share price for PTX : $0.055

ASX company news and announcements for Prescient Therapeutics Limited (PTX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Prescient Therapeutics Limited (PTX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Prescient Therapeutics Limited (PTX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Prescient Therapeutics Limited (PTX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$63 Appendix 4E and 2026 Annual Report 21 Aug 2026 9:32AM $0.077 $0.055 fallen by 28.57%
$63 June 2026 Quarterly Update and Appendix 4C 27 Jul 2026 12:36PM $0.087 $0.055 fallen by 36.78%
$63 Notification of cessation of securities - PTX 10 Jul 2026 2:53PM $0.072 $0.055 fallen by 23.61%
$63 PTX Dr Rosalind Wilson appointed as Chief Medical Officer 11 Jun 2026 10:03AM $0.065 $0.055 fallen by 15.38%
$63 Response to ASX Price Query 15 May 2026 9:01AM $0.069 $0.055 fallen by 20.29%
$63 Investor Presentation 30 Apr 2026 9:37AM $0.051 $0.055 risen by 7.84%
$63 March 2026 Quarterly Update and Appendix 4C 30 Apr 2026 9:25AM $0.051 $0.055 risen by 7.84%
$63 Updated Securities Trading Policy 25 Feb 2026 9:03AM $0.063 $0.055 fallen by 12.70%
$63 Appendix 4D and Half Year Financial Report 24 Feb 2026 5:00PM $0.063 $0.055 fallen by 12.70%
$63 December 2025 Quarterly Update and Appendix 4C 30 Jan 2026 9:16AM $0.076 $0.055 fallen by 27.63%
$63 Notification regarding unquoted securities - PTX 19 Dec 2025 1:18PM $0.105 $0.055 fallen by 47.62%
$63 PTX secures EU Authorisation to commence PTX-100 Trial 15 Dec 2025 9:10AM $0.089 $0.055 fallen by 38.20%
$63 Change of Director's Interest Notice 21 Nov 2025 10:03AM $0.058 $0.055 fallen by 5.17%
$63 Change of Director's Interest Notice 21 Nov 2025 10:02AM $0.058 $0.055 fallen by 5.17%
$63 Change of Director's Interest Notice 21 Nov 2025 10:01AM $0.058 $0.055 fallen by 5.17%
$63 Change of Director's Interest Notice 21 Nov 2025 10:00AM $0.059 $0.055 fallen by 6.78%
$63 Change of Director's Interest Notice 21 Nov 2025 9:57AM $0.059 $0.055 fallen by 6.78%
$63 PTX secures EU Orphan Drug Designation for PTX-100 in CTCL 19 Nov 2025 9:02AM $0.048 $0.055 risen by 14.58%
$63 Notification regarding unquoted securities - PTX 18 Nov 2025 10:25AM $0.048 $0.055 risen by 14.58%
$63 Amended Constitution 28 Oct 2025 2:34PM $0.049 $0.055 risen by 12.24%
$63 Results of Annual General Meeting 14 Oct 2025 4:42PM $0.043 $0.055 risen by 27.91%
$63 Chair Address and CEO AGM Presentation 14 Oct 2025 10:43AM $0.043 $0.055 risen by 27.91%
$63 September Quarterly Updated and Appendix 4C 10 Oct 2025 9:07AM $0.044 $0.055 risen by 25%
$63 Notice of Annual General Meeting/Proxy Form 12 Sep 2025 10:54AM $0.040 $0.055 risen by 37.50%
$63 Notification regarding unquoted securities - PTX 1 Sep 2025 5:04PM $0.041 $0.055 risen by 34.15%

26 - 50 of 596 results

Page 2 of 24

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.